Skip to content

Modified Atkins Diet and Type 2 Diabetic Patients

Influende of a Modified Atkins Diet on Glucose Metabolism and Weight Loss in Obese Type 2 Diabetic Patients - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00552890
Enrollment
52
Registered
2007-11-02
Start date
2001-12-31
Completion date
2004-02-29
Last updated
2007-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Type 2 Diabetic Patients

Keywords

obesity, atkins, weight reduction, kidney function

Brief summary

This randomized control trial compared the influence of an Atkins diet to that of the ADA recommended diet on Type 2 diabetic obese patients during a one-year follow-up period

Interventions

OTHERmodified Atkins diet

subjects assigned to follow modified Atkins diet for 1 year

OTHERADA recommended diet

subjects assigned to follow ADA recommended diet for period of 1 year

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetic patients age 35-75 years * BMI 30-39.9kg/m * HbA1C\>7% * Not receiving insulin * Micro-albumin excretion\<60 mg/day

Exclusion criteria

* Serum creatinine level \> 1.4 mg per deciliter * Diastolic blood pressure \> 100 mmHg or systolic blood pressure \> 180mmHg * Liver disease * LDL cholesterol \> 160 mg per deciliter despite lipid-lowering treatment * Use of psychiatric medications * Osteoporosis * Cancer * Food allergies, and * Low carbohydrate diet in the past 6 months.

Design outcomes

Primary

MeasureTime frame
weight loss and glucose control1 year

Secondary

MeasureTime frame
lipid profile, kidney function1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026